Vanguard Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Vanguard Asset Management's TARS Position: Q3 2026 in Review
Vanguard Asset Management increased its Tarsus Pharmaceuticals (TARS) stake by 11% in Q3 2026, buying an estimated $156K and bringing the position to 22,987 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1602.
Vanguard Asset Management first reported a position in TARS in Q1 2026 and has held it in 3 quarters since. 176 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Vanguard Asset Management held 22,987 shares of Tarsus Pharmaceuticals worth $1.81M as of Q3 2026.
- Vanguard Asset Management bought 2,239 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $156K.
- Tarsus Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1602 holding.
- Vanguard Asset Management first reported a position in Tarsus Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 176 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.